To view this, you need to install the Flash Player 5. Please go to here and download it.

Personal Injury Blog

The Locks Law Firm is Investigating the Tragic Amtrak Train 188 Accident

May 15, 2015 @ 03:43 PM — by Admin

On May 12, 2015, Amtrak Northeast Regional Train 188 was involved in a devastating accident which killed eight people and sent more than 200 to local hospitals. The Locks Law Firm is sorry to hear of this incident and wishes to express that the victims and their families are in our thoughts.  Unfortunately, information has come to light to support the conclusion that the negligence of Amtrak and its employees were responsible for the tragic accident. The Locks Law Firm has a history of representing clients and their families who are victims of transportation-related accidents. If you or a loved one was involved in the Amtrak Northeast Regional Train 188 accident, contact the Locks Law Firm today at (215) 893-0100. 

Passenger Train Safety

May 14, 2015 @ 04:50 PM — by Admin

Andrew DuPont, a partner at the Locks Law Firm in our Philadelphia office, which represents clients in transportation-related cases, was asked to provide an expert opinion on train safety in light of the recent Amtrak crash.  Read what he had to say regarding the safety of our rail system.


Actos Bladder Cancer Lawsuits Tentatively Settle for $2.4 Billion

April 29, 2015 @ 03:38 PM — by Admin

Tekeda Pharmaceutical has agreed to pay approximately $2.4 billion to settle 9,000 Actos lawsuits across the county. The Locks Law Firm represents a number of clients involved in the litigation and is pleased to announce that Takeda has agreed to compensate thousands of bladder cancer victims and their families.

The lawsuits accused Takeda of concealing the risk of bladder cancer and manufacturing a defective, unreasonably dangerous drug. Although Takeda has refused to admit liability, the settlement is an important step for compensating individuals and their families who have been harmed by Actos.

FDA Issues Drug Safety Communication for Testosterone

March 06, 2015 @ 03:05 PM — by Admin
On March 3, 2015, the FDA issued a Drug Safety Communication concerning Testosterone drugs. Based on published studies and expert input from an Advisory Committee meeting, the FDA concluded that there is a possible increased cardiovascular risk associated with testosterone drugs and that some studies report an increased risk of heart attack, stroke and death associated with testosterone drugs. As a result, the FDA is requiring labeling changes for all prescription testosterone drugs to reflect the potential increased risk of heart attacks and strokes from the use of testosterone products. The timing of the FDA’s announcement is noteworthy as more than 1,100 Testosterone lawsuits are pending against the manufacturers of Testosterone drugs. 

Johnson & Johnson Settles First Mesh Cases

February 04, 2015 @ 12:31 PM — by Admin
Tagged with:

Transvaginal mesh is a dangerous implant used to treat stress urinary incontinence (SUI) and pelvic organ prolapse (POP) in women....Importantly, plaintiffs achieved a significant victory as Johnson & Johnson (“J & J”), a prominent manufacturer of such implants, agreed to settle four cases for the first time since the litigation against them began.  The company currently faces more than 23,000 lawsuits over the mesh implants, and the settlements are a step in the right direction for plaintiffs.  

Risperdal Lawsuits Continue to Mount

January 07, 2015 @ 10:44 AM — by Admin
Tagged with: Risperdal
Risperdal is an atypical antipsychotic approved by the U.S Food & Drug Administration to treat schizophrenia, bipolar disorder, and irritability in children with autistic disorder. Unfortunately, the medication has proven to pose serious risks to male children and adults, including gynecomastia (male chest growth) and significant weight gain. As of December 2014, 2014, court documents indicate that 1,183 claims have been filed in Pennsylvania on behalf of individuals who developed gynecomastia or other serious complications. This represents an increase of more than 100 filings in the past month. (In Re: Risperdal Litigation, Case Number 100300296). 

Plan to Establish $135 Million Fund for NECC Fungal Meningitis Claimants Has Been Filed

December 05, 2014 @ 10:09 AM — by Admin
Two years after New England Compounding Center (NECC) sent contaminated injectable steroids to pain clinics in  several states, there is now a Plan to establish a fund of $135 million for persons with fungal meningitis caused by this contamination. Over 750 people have been sickened and over 60 people have died from the tainted steroids. NECC declared bankruptcy in 2012 but now the Trustee for it has filed this Plan in federal Bankruptcy Court. It is hoped that this Plan will receive final formal approval from the Bankruptcy Court in the spring of 2015.

If You Thought the Sale of Asbestos Was Illegal, Think Again

December 04, 2014 @ 04:09 PM — by Admin
Tagged with:
Many clients in the asbestos litigation are shocked to learn that the sale of asbestos is not illegal. Even in 2014, where people continue to die of mesothelioma and other asbestos-related diseases, it remains legal to import asbestos, manufacture asbestos products, and sell asbestos products. No matter what your politics are, you SHOULD be shocked to learn that Congress cannot pass a bill to ban asbestos. Democratic Senator Patty Murray (D-Wa) and Democratic Senator Barbara Boxer (D-Ca) fought to pass such a bill, banning asbestos, called the Ban Asbestos in America Act", several years ago. While it initially passed in the Senate, the bill ultimately did not become law.

Did BASF and/or Asbestos Defense Lawyers Destroy Evidence?

December 04, 2014 @ 11:13 AM — by Admin
Tagged with:

The daughter of an engineer who worked at Engelhard Corporation (a New Jersey company) contracted mesothelioma, a form of cancer caused only by asbestos in the United States. She claimed in the lawsuit that her father brought asbestos home on his clothes and also claimed exposure when she would visit him at work. The suit claimed that the talc at the Engelhard plant was contaminated with asbestos. At the time of the lawsuit, Engelhard no longer existed because a huge German chemical company, BASF SE, had  bought it. For years, Engelhard, and then BASF, and defense lawyers at the Cahill Gordon & Reindel lawfirm, maintained in thousands of asbestos cases that Engelhard's talc was asbestos-free. Now there is a lawsuit filed against BASF and also the Cahill lawfirm, claiming that they conspired to prevent injured or deceased plaintiffs from receiving compensation for their asbestos disease. 

Device Used in Hysterectomies May Cause the Spread of Cancer

November 24, 2014 @ 01:23 PM — by Admin
Tagged with:

Today the FDA warned against using a medical device called "Laparoscopic Power Morcellators" to remove uterus fibroids (i.e., hysterectomies). In fact, the FDA Notice was categorized as an "Immediately In Effect " (IIE) Guidance. In addition the FDA recommended that the companies that make the Laparoscopic Power Morcellators include safety statements in the form of "Boxed Warnings" and two (2) Contraindications. The boxed warning should include the fact that these devices may actually cause the spread of existing cancer which would decrease the long-term survival of patients. 

Share |

Back to top